Is FDC the Best Stock in Its Sector? A Look at the Numbers

FDC CMP Rs 345 (25 Sep 2026). Market cap Rs 5,627 Cr. ROE 11.32%. P/E 19.23x versus Industry P/E 38.64x.

Is FDC the best stock in its sector? The stock trades on the NSE at Rs 345 as of 25 September 2026, within its 52-week range of Rs 312.95 to Rs 484.40. FDC Ltd manufactures pharmaceutical formulations across multiple therapeutic segments.

FDC sits in the Healthcare sector, and its 11.32% ROE and 19.23x P/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector’s Industry P/E benchmark.

Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers

Click Here – Get Free Investment Predictions

About FDC

FDC Ltd manufactures pharmaceutical formulations across multiple therapeutic segments. It manufactures pharmaceutical formulations across multiple therapeutic segments, and the stock is trading near its 52-week low. At a market capitalisation of Rs 5,627 Cr, it is tracked as part of the Healthcare sector on Univest.

Is FDC the Best Stock in Its Sector?

FDC makes its case as the best stock in its sector primarily on valuation relative to its Industry P/E, combining a 11.32% ROE with a 19.23x P/E against the sector’s 38.64x Industry P/E. FDC’s 19.23x P/E is well below the 38.64x Industry P/E despite an 11.32% ROE, making it look inexpensive relative to CORONA Remedies and other Healthcare peers covered in this series, though the stock is trading near its 52-week low.

Metric	FDC
CMP (NSE)	Rs 344.55
52-Week High / Low	Rs 484.40 / Rs 312.95
Market Cap	Rs 5,627 Cr
P/E (TTM) vs Industry P/E	19.23x vs 38.64x
P/B	2.26
ROE	11.32%
EPS (TTM)	Rs 17.97
Dividend Yield	1.45%
Debt to Equity	0.01

Compare FDC Against Other Healthcare Sector Stocks

How FDC Compares Against Its Healthcare Sector Peers

The table below sets FDC against 2 other Healthcare sector names, using the same live data source for every company. A peer average row is included for P/E, ROE and debt to equity, calculated across the 2 peer companies.

Company	Market Cap (Rs Cr)	P/E	ROE	Debt to Equity
FDC	5,627	19.23	11.32%	0.01
CORONA Remedies	13,237	66.51	24.79%	0.22
Entero Healthcare Solutions	8,069	48.13	6.81%	0.40
Peer average (2 companies)	–	57.32	15.80%	0.31

Against this peer set, FDC’s 11.32% ROE is below the 15.80% peer average, and its P/E of 19.23x runs below the peer average of 57.32x. FDC’s 19.23x P/E is well below the 38.64x Industry P/E despite an 11.32% ROE, making it look inexpensive relative to CORONA Remedies and other Healthcare peers covered in this series, though the stock is trading near its 52-week low.

What Makes FDC Worth Watching in Healthcare

• Well below Industry P/E: A 19.23x P/E against a 38.64x Industry P/E is a significant discount for a business with an 11.32% ROE.
• Solid ROE: An 11.32% ROE is a reasonable figure for a diversified pharmaceutical formulations manufacturer.
• Near debt free: A debt to equity ratio of 0.01 gives FDC significant balance sheet flexibility.

FDC Valuation: Is It Justified?

FDC’s 19.23x P/E is well below the 38.64x Industry P/E despite an 11.32% ROE, making it look inexpensive relative to CORONA Remedies and other Healthcare peers covered in this series, though the stock is trading near its 52-week low. As with any single stock, investors should weigh this against their own valuation discipline and risk appetite rather than the sector label alone.

Also read – Is Eureka Forbes the Best Stock in Its Sector? A Look at the Numbers

Download the Univest iOS App or Univest Android App to track FDC and other Healthcare sector stocks.

How to Track FDC Before You Invest

Before deciding whether FDC deserves its label as the best stock in its sector for your own portfolio, compare it directly against Healthcare sector peers using the steps below.

1. Open the Univest Screener and search for FDC to view live price, valuation ratios, and peer comparisons within the Healthcare sector.
2. Compare its P/E, P/B, and ROE against other Healthcare sector stocks before deciding if the current valuation fits your strategy.
3. Set a price alert around key support and resistance zones using the Univest app so you are notified of meaningful moves.
4. Open a broking account on Univest if you decide to add the stock, and size the position based on your own risk appetite and portfolio allocation.

Conclusion

FDC earns a place in the best stock in its sector conversation on the strength of a 11.32% ROE and a P/E of 19.23x against a 38.64x Industry P/E, with named peer comparisons in this article backing up that picture. As with any individual stock decision, this analysis is educational and investors should do their own research or consult a SEBI-registered advisor before investing.

Is FDC the best stock in its sector?

Ans. FDC has a 11.32% ROE and trades at 19.23x P/E against a 38.64x Industry P/E, and compares below the peer average ROE of 15.80% in this article’s named comparison, so the answer depends on what an investor is prioritising.

What is the current share price of FDC?

Ans. FDC was trading at Rs 344.55 on the NSE as of 25 September 2026, within its 52-week range of Rs 312.95 to Rs 484.40.

What sector does FDC belong to?

Ans. FDC is classified under the Healthcare sector on Univest.

How does FDC compare to its sector peers on P/E?

Ans. FDC’s P/E of 19.23x is below the 57.32x average of the 2 named peers compared in this article.

What is FDC’s return on equity?

Ans. FDC reported a return on equity of 11.32%, which is below the 15.80% average of its named peers in this comparison.

Should I invest in FDC based on its sector position?

Ans. FDC’s sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.